DOI: 10.1055/s-00000075

Seminars in Respiratory and Critical Care Medicine

References

Davis MR, Donnelley MA, Thompson GR.
Ibrexafungerp: a novel oral glucan synthase inhibitor.

Med Mycol 2019; (e-pub ahead of print)
DOI: 10.1093/mmy/myz083.

Download Bibliographical Data

Search in: